申请人:Inspire Pharmaceuticals, Inc.
公开号:US08158796B2
公开(公告)日:2012-04-17
The present invention is directed to practical high-yielding synthetic processes to prepare compounds of general Formula III, IV, V, VII, VIII, IX, X, XII, XIV, and XV. Such compounds are useful as final products or can be used as intermediates and be further modified to prepare other desired products such as rho-kinase inhibitors. The present invention is also directed to certain novel compounds and/or novel solid forms of certain compounds.
本发明旨在提供实用的高产率合成过程,以制备通式III、IV、V、VII、VIII、IX、X、XII、XIV和XV的化合物。这些化合物可用作最终产品,也可以用作中间体,并进一步改性以制备其他所需产品,如Rho激酶抑制剂。本发明还涉及某些新颖化合物和/或某些化合物的新颖固体形式。